The recurring revenue story behind Bit Digital BTBT Q4 2025 Earnings Underperform OKTA Okta tops Q1 2026 consensus EPS estimates investor optimism pushes stock up nearly three percent today Why Nasus Pharma NSRX looks solid from every angle Investors Pile In 20260508 BLTE Belite Bio misses Q4 earnings estimates by 256 percent posts zero revenue shares dip slightly